216 related articles for article (PubMed ID: 36924409)
1. Foetal genome editing.
Bose SK; Kennedy K; Peranteau WH
Curr Opin Obstet Gynecol; 2023 Apr; 35(2):134-139. PubMed ID: 36924409
[TBL] [Abstract][Full Text] [Related]
2. Society for Maternal-Fetal Medicine Special Statement: Beyond the scalpel: in utero fetal gene therapy and curative medicine.
; Shanahan MA; Aagaard KM; McCullough LB; Chervenak FA; Shamshirsaz AA
Am J Obstet Gynecol; 2021 Dec; 225(6):B9-B18. PubMed ID: 34537158
[TBL] [Abstract][Full Text] [Related]
3. Molecular and Cellular In Utero Therapy.
Berkowitz CL; Luks VL; Puc M; Peranteau WH
Clin Perinatol; 2022 Dec; 49(4):811-820. PubMed ID: 36328600
[TBL] [Abstract][Full Text] [Related]
4. Therapy Development by Genome Editing of Hematopoietic Stem Cells.
Koniali L; Lederer CW; Kleanthous M
Cells; 2021 Jun; 10(6):. PubMed ID: 34198536
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in genome editing for cardiovascular disease.
Doerfler AM; Walkey CJ; Lagor WR
Curr Opin Cardiol; 2020 May; 35(3):242-248. PubMed ID: 32073405
[TBL] [Abstract][Full Text] [Related]
6. Genome Editing of Monogenic Neuromuscular Diseases: A Systematic Review.
Long C; Amoasii L; Bassel-Duby R; Olson EN
JAMA Neurol; 2016 Nov; 73(11):1349-1355. PubMed ID: 27668807
[TBL] [Abstract][Full Text] [Related]
7. Gene regulatory and gene editing tools and their applications for retinal diseases and neuroprotection: From proof-of-concept to clinical trial.
Altay HY; Ozdemir F; Afghah F; Kilinc Z; Ahmadian M; Tschopp M; Agca C
Front Neurosci; 2022; 16():924917. PubMed ID: 36340792
[TBL] [Abstract][Full Text] [Related]
8. Genome editing, a superior therapy for inherited retinal diseases.
Yan AL; Du SW; Palczewski K
Vision Res; 2023 May; 206():108192. PubMed ID: 36804635
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application.
Alapati D; Morrisey EE
Am J Respir Cell Mol Biol; 2017 Mar; 56(3):283-290. PubMed ID: 27780343
[TBL] [Abstract][Full Text] [Related]
10. In utero CRISPR-mediated therapeutic editing of metabolic genes.
Rossidis AC; Stratigis JD; Chadwick AC; Hartman HA; Ahn NJ; Li H; Singh K; Coons BE; Li L; Lv W; Zoltick PW; Alapati D; Zacharias W; Jain R; Morrisey EE; Musunuru K; Peranteau WH
Nat Med; 2018 Oct; 24(10):1513-1518. PubMed ID: 30297903
[TBL] [Abstract][Full Text] [Related]
11. Delivery technologies for in utero gene therapy.
Palanki R; Peranteau WH; Mitchell MJ
Adv Drug Deliv Rev; 2021 Feb; 169():51-62. PubMed ID: 33181188
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for
Wei T; Cheng Q; Farbiak L; Anderson DG; Langer R; Siegwart DJ
ACS Nano; 2020 Aug; 14(8):9243-9262. PubMed ID: 32697075
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
14. A Curative DNA Code for Hematopoietic Defects: Novel Cell Therapies for Monogenic Diseases of the Blood and Immune System.
Porteus MH; Pavel-Dinu M; Pai SY
Hematol Oncol Clin North Am; 2022 Aug; 36(4):647-665. PubMed ID: 35773054
[TBL] [Abstract][Full Text] [Related]
15. Prenatal interventions for congenital diaphragmatic hernia for improving outcomes.
Grivell RM; Andersen C; Dodd JM
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008925. PubMed ID: 26611822
[TBL] [Abstract][Full Text] [Related]
16. The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation.
Dever DP; Porteus MH
Curr Opin Hematol; 2017 Nov; 24(6):481-488. PubMed ID: 28806273
[TBL] [Abstract][Full Text] [Related]
17. Precise somatic genome editing for treatment of inborn errors of immunity.
Meng Q; Sun H; Liu J
Front Immunol; 2022; 13():960348. PubMed ID: 36091069
[TBL] [Abstract][Full Text] [Related]
18. In utero nanoparticle delivery for site-specific genome editing.
Ricciardi AS; Bahal R; Farrelly JS; Quijano E; Bianchi AH; Luks VL; Putman R; López-Giráldez F; Coşkun S; Song E; Liu Y; Hsieh WC; Ly DH; Stitelman DH; Glazer PM; Saltzman WM
Nat Commun; 2018 Jun; 9(1):2481. PubMed ID: 29946143
[TBL] [Abstract][Full Text] [Related]
19. Gene Editing for the Treatment of Primary Immunodeficiency Diseases.
Rai R; Thrasher AJ; Cavazza A
Hum Gene Ther; 2021 Jan; 32(1-2):43-51. PubMed ID: 32935622
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing for Mucopolysaccharidoses.
Poletto E; Baldo G; Gomez-Ospina N
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
